Abstract
Introduction: A critical surgical goal for oral cancer is achieving negative resection margins with no residual malignant cells, to prevent disease recurrence. The quantitative Malignancy Index Diagnostic System (qMIDS) is the first FOXM1 oncogene-based diagnostic test developed for quantifying oral squamous cell carcinoma. This highly sensitive technique converts gene expression into a digital index to quantify cancer risk.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
